1-11 of 11
Clicerio Gonzalez-Villalpando
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas

Free
Alexandro J. Martagón, Omar Yaxmehen Bello-Chavolla, Olimpia Arellano-Campos, Paloma Almeda-Valdés, Geoffrey A. Walford, Ivette Cruz-Bautista, Donají V. Gómez-Velasco, Roopa Mehta, Liliana Muñoz-Hernández, Magdalena Sevilla-González, Tannia L. Viveros-Ruiz, María Luisa Ordoñez-Sánchez, Rosario Rodríguez-Guillen, Jose C. Florez, María Teresa Tusié-Luna, Carlos A. Aguilar-Salinas, Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium, Josep M. Mercader, Alicia Huerta-Chagoya, Hortensia Moreno-Macías, Humberto García-Ortiz, Alisa Manning, Lizz Caulkins, Jason Flannick, Nick Patterson, Angélica Martínez-Hernández, Federico Centeno-Cruz, Francisco Martin Barajas-Olmos, Carlos Zerrweck, Cecilia Contreras-Cubas, Elvia Mendoza-Caamal, Cristina Revilla-Monsalve, Sergio Islas Andrade, Emilio Córdova, Xavier Soberón, María Elena González-Villalpando, Lynne Wilkens, Loic Le Marchand, Kristine Monroe, Laurence Kolonel, Olimpia Arellano-Campos, María L. Ordóñez-Sánchez, Maribel Rodríguez-Torres, Yayoi Segura-Kato, Rosario Rodríguez-Guillén, Ivette Cruz-Bautista, Linda Liliana Muñoz-Hernández, Alexandro J. Martagón, Magdalena del Rocio Sevilla Gonzalez, Donají Gómez, Paloma Almeda-Valdés, Maria Eugenia Garay, Juan Manuel Malacara Hernandez, Noël P. Burtt, Maria L. Cortes, David M. Altshuler, Christopher A. Haiman, Carlos A. Aguilar-Salinas, Clicerio González-Villalpando, Lorena Orozco, Teresa Tusié-Luna, Jose C. Florez
Journal: Diabetes Care
Diabetes Care 2018;41(8):1726–1731
https://doi.org/10.2337/dc18-0384
Published: 29 May 2018
View articletitled, Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas
Open the PDF for Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas in another window
Includes: Supplementary data
Journal Articles

Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study

Free
Monica Nannipieri, MD, Rosalinda Posadas, PHD, Alessandra Bonotti, BM, Ken Williams, Clicerio Gonzalez-Villalpando, MD, Michael P. Stern, MD, Ele Ferrannini, MD
Journal: Diabetes Care
Diabetes Care 2006;29(11):2509–2511
https://doi.org/10.2337/dc06-0355
Published: 01 November 2006
View articletitled, Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study
Open the PDF for Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study in another window
Journal Articles

Design and Validation of a Population-Based Definition of the Metabolic Syndrome

Free
Carlos A. Aguilar-Salinas, MD, Rosalba Rojas, MD, Clicerio Gonzalez-Villalpando, MD, Francisco J. Gómez-Pérez, MD, Roopa Mehta, MD, Gustavo Olaiz, MD, PHD, Juan A. Rull, MD, David R. Cox, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(11):2420–2426
https://doi.org/10.2337/dc06-0611
Published: 01 November 2006
View articletitled, Design and Validation of a Population-Based Definition of the Metabolic Syndrome
Open the PDF for Design and Validation of a Population-Based Definition of the Metabolic Syndrome in another window
Journal Articles

Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects

Free
Carlos Lorenzo, MD, Manuel Serrano-Ríos, MD, María T. Martínez-Larrad, PHD, José L. González-Sánchez, PHD, Segundo Seclén, MD, Arturo Villena, MD, Clicerio Gonzalez-Villalpando, MD, Ken Williams, MS, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2006;29(3):685–691
https://doi.org/10.2337/diacare.29.03.06.dc05-1796
Published: 01 March 2006
View articletitled, Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects
Open the PDF for Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects in another window
Journal Articles

The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity

Free
Carlos Lorenzo, MD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2480–2485
https://doi.org/10.2337/diacare.28.10.2480
Published: 01 October 2005
View articletitled, The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity
Open the PDF for The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity in another window
Journal Articles

Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al.

Free
Naveed Sattar, MD, PHD, Ken Williams, MS, Thang S. Han, MD, PHD, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2003;26(5):1657–1658
https://doi.org/10.2337/diacare.26.5.1657
Published: 01 May 2003
View articletitled, Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al.
Open the PDF for Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. in another window
Journal Articles

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Free
Thang S. Han, MD, PHD, Naveed Sattar, MD, PHD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2002;25(11):2016–2021
https://doi.org/10.2337/diacare.25.11.2016
Published: 01 November 2002
View articletitled, Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
Open the PDF for Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study in another window
Journal Articles

Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico

Free
James P. Burke, PHD, Ken Williams, MS, Steven M. Haffner, MD, Clicerio Gonzalez Villalpando, MD, FACP, Michael P. Stern, MD
Journal: Diabetes Care
Diabetes Care 2002;25(5):938–939
https://doi.org/10.2337/diacare.25.5.938
Published: 01 May 2002
View articletitled, Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico
Open the PDF for Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico in another window
Journal Articles

Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?: The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study

Free
Carlos Lorenzo, MD, Manel Serrano-Rios, MD, Maria T. Martinez-Larrad, MD, Rafael Gabriel, MD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Michel P. Stern, MD, Helen P. Hazuda, PHD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2001;24(12):2059–2064
https://doi.org/10.2337/diacare.24.12.2059
Published: 01 December 2001
View articletitled, Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?: The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study
Open the PDF for Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?: The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study in another window
Journal Articles

Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico

Free
James P. Burke, PHD, Ken Williams, MS, Steven M. Haffner, MD, Clicerio Gonzalez Villalpando, MD, FACP, Michael P. Stern, MD
Journal: Diabetes Care
Diabetes Care 2001;24(9):1573–1578
https://doi.org/10.2337/diacare.24.9.1573
Published: 01 September 2001
View articletitled, Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico
Open the PDF for Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico in another window
Journal Articles

Moderate-to-Severe Diabetic Retinopathy Is More Prevalent in Mexico City Than in San Antonio, Texas

Free
Maria Elena González Villalpando, MD, Clicerio González Villalpando, MD, Beatriz Arredondo Pérez, MD, Sandra Virginia Martínez Díaz, BS, Braxton Mitchell, PHD, David Rivera Martínez, RDMS, Ronald Klein, MD, MPH, Steven M Haffner, MD, MPH, Michael P Stern, MD
Journal: Diabetes Care
Diabetes Care 1997;20(5):773–777
https://doi.org/10.2337/diacare.20.5.773
Published: 01 May 1997
View articletitled, Moderate-to-Severe Diabetic Retinopathy Is More Prevalent in Mexico City Than in San Antonio, Texas
Open the PDF for Moderate-to-Severe Diabetic Retinopathy Is More Prevalent in Mexico City Than in San Antonio, Texas in another window